The PI3K/Akt pathway: a target for curcumin’s therapeutic effects
Тип публикации: Journal Article
Дата публикации: 2025-01-17
SCImago Q2
WOS Q3
БС3
SJR: 0.583
CiteScore: 3.4
Impact factor: 2.1
ISSN: 22516581
Краткое описание
The purpose of this review study is to investigate the effect of curcumin on the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway in various diseases. Curcumin, the main compound found in turmeric, has attracted a lot of attention for its diverse pharmacological properties. These properties have increased the therapeutic potential of curcumin in chronic diseases such as cardiovascular disease, Type 2 diabetes, obesity, non-alcoholic fatty liver disease, kidney disease, and neurodegenerative diseases. One of the main mechanisms of the effect of curcumin on health is its ability to modulate the PI3K/Akt signaling pathway. This pathway plays an important role in regulating vital cellular processes such as growth, cell survival, metabolism, and apoptosis. Disruption of the PI3K/Akt signaling pathway is associated with the incidence of several diseases. Electronic databases including PubMed, Google Scholar, and Scopus were searched with the keywords “phosphoinositide 3-kinase” AND “protein kinase B “AND “curcumin” in the title/abstract. Also, following keywords “non-alcoholic fatty liver disease” AND “diabetes” AND “obesity” AND “kidney disease” and “neurodegenerative diseases” was searched in the whole text. Research indicates that curcumin offers potential benefits for several health conditions. Studies have shown it can help regulate blood sugar, reduce inflammation, and protect the heart, kidneys, and brain. This protective effect is partially achieved by regulating the PI3K-Akt survival pathway, which helps improve metabolic disorders and oxidative stress. By examining how curcumin affects this vital cell pathway, researchers can discover new treatment strategies for a range of diseases.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Топ-30
Журналы
|
1
2
|
|
|
Nutrients
2 публикации, 11.76%
|
|
|
Frontiers in Immunology
1 публикация, 5.88%
|
|
|
Clinical Nurse Specialist
1 публикация, 5.88%
|
|
|
Russian Chemical Reviews
1 публикация, 5.88%
|
|
|
Scientific Reports
1 публикация, 5.88%
|
|
|
International Journal of Biological Macromolecules
1 публикация, 5.88%
|
|
|
Open Medicine (Poland)
1 публикация, 5.88%
|
|
|
Inflammopharmacology
1 публикация, 5.88%
|
|
|
BMC Nephrology
1 публикация, 5.88%
|
|
|
RSC Advances
1 публикация, 5.88%
|
|
|
Frontiers in Physiology
1 публикация, 5.88%
|
|
|
Chemistry and Biodiversity
1 публикация, 5.88%
|
|
|
International Journal of Environmental Health Research
1 публикация, 5.88%
|
|
|
Bioscience Reports
1 публикация, 5.88%
|
|
|
Pharmacognosy Magazine
1 публикация, 5.88%
|
|
|
Toxins
1 публикация, 5.88%
|
|
|
1
2
|
Издатели
|
1
2
3
4
|
|
|
Springer Nature
4 публикации, 23.53%
|
|
|
MDPI
3 публикации, 17.65%
|
|
|
Frontiers Media S.A.
2 публикации, 11.76%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 публикация, 5.88%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 5.88%
|
|
|
Elsevier
1 публикация, 5.88%
|
|
|
De Gruyter Brill
1 публикация, 5.88%
|
|
|
Royal Society of Chemistry (RSC)
1 публикация, 5.88%
|
|
|
Wiley
1 публикация, 5.88%
|
|
|
Taylor & Francis
1 публикация, 5.88%
|
|
|
SAGE
1 публикация, 5.88%
|
|
|
1
2
3
4
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Войти с ORCID
Метрики
17
Всего цитирований:
17
Цитирований c 2025:
17
(100%)
Цитировать
ГОСТ |
RIS |
BibTex
Цитировать
ГОСТ
Скопировать
Aliyari M. et al. The PI3K/Akt pathway: a target for curcumin’s therapeutic effects // Journal of Diabetes and Metabolic Disorders. 2025. Vol. 24. No. 1. 52
ГОСТ со всеми авторами (до 50)
Скопировать
Aliyari M., Ghoflchi S., Hashemy S. I., Hashemi S. F., Reihani A., Hosseini H. The PI3K/Akt pathway: a target for curcumin’s therapeutic effects // Journal of Diabetes and Metabolic Disorders. 2025. Vol. 24. No. 1. 52
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1007/s40200-025-01563-2
UR - https://link.springer.com/10.1007/s40200-025-01563-2
TI - The PI3K/Akt pathway: a target for curcumin’s therapeutic effects
T2 - Journal of Diabetes and Metabolic Disorders
AU - Aliyari, Mahdieh
AU - Ghoflchi, Sahar
AU - Hashemy, Seyed Isaac
AU - Hashemi, Seyedeh Fatemeh
AU - Reihani, Amirali
AU - Hosseini, Hossein
PY - 2025
DA - 2025/01/17
PB - Springer Nature
IS - 1
VL - 24
SN - 2251-6581
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2025_Aliyari,
author = {Mahdieh Aliyari and Sahar Ghoflchi and Seyed Isaac Hashemy and Seyedeh Fatemeh Hashemi and Amirali Reihani and Hossein Hosseini},
title = {The PI3K/Akt pathway: a target for curcumin’s therapeutic effects},
journal = {Journal of Diabetes and Metabolic Disorders},
year = {2025},
volume = {24},
publisher = {Springer Nature},
month = {jan},
url = {https://link.springer.com/10.1007/s40200-025-01563-2},
number = {1},
pages = {52},
doi = {10.1007/s40200-025-01563-2}
}
Ошибка в публикации?